Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Clinical Therapeutics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.clinthera.2007.12.002PMID 18164920
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An Evaluation of the Cardiovascular Safety Profile of Duloxetine

  2007cited by this paper
• Effects of treatments for symptoms of painful diabetic neuropathy: systematic review

  2007cited by this paper
• EFNS guidelines on pharmacological treatment of neuropathic pain

  2006cited by this paper
• A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain

  2006cited by this paper
• Central nervous system mechanisms of pain modulation

  2006cited by this paper
• Treatment benefits of duloxetine in major depressive disorder as assessed by number needed to treat

  2006cited by this paper
• Duloxetine vs. placebo in patients with painful diabetic neuropathy

  2005cited by this paper
• Algorithm for neuropathic pain treatment: An evidence based proposal

  2005cited by this paper
• A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.

  2005cited by this paper
• Number Needed to Treat (or Harm)

  2005cited by this paper
• Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double‐blind, placebo‐controlled study

  2004cited by this paper
• Effects of duloxetine on painful physical symptoms associated with depression.

  2004cited by this paper
• Efficacy and safety of venlafaxine ER vs. amitriptyline ER in patients with major depression of moderate severity.

  2004cited by this paper
• Duloxetine in the Treatment of Depression: A Double-Blind Placebo-Controlled Comparison With Paroxetine

  2004cited by this paper
• Venlafaxine versus imipramine in painful polyneuropathy

  2003cited by this paper
• Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression.

  2002cited by this paper
• Dextromethorphan and Memantine in Painful Diabetic Neuropathy and Postherpetic Neuralgia: Efficacy and Dose-Response Trials

  2002cited by this paper
• Meta-analysis, Simpson's paradox, and the number needed to treat

  2002cited by this paper
• Pooling data for Number Needed to Treat: no problems for apples

  2002cited by this paper
• How well do antidepressants work in older people? A systematic review of Number Needed to Treat.

  2002cited by this paper
• Reporting number needed to treat and absolute risk reduction in randomized controlled trials.

  2002cited by this paper
• Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.

  2002cited by this paper
• Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.

  2002cited by this paper
• Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine

  2002cited by this paper
• Central nervous system mechanisms of pain

  2002cited by this paper
• Pharmacologic treatment of pain in polyneuropathy

  2000cited by this paper
• Defining the clinically important difference in pain outcome measures

  2000cited by this paper
• Calculating the number needed to treat for trials where the outcome is time to an event

  1999cited by this paper
• Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses.

  1999cited by this paper
• Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

  1999cited by this paper
• Improving the Quality of Reports of Meta-Analyses of Randomised Controlled Trials: The QUOROM Statement

  1999cited by this paper
• High‐dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia

  1997cited by this paper
• Using Numerical Results from Systematic Reviews in Clinical Practice

  1997cited by this paper
• Long‐term efficacy and safety of milnacipran compared to clomipramine in patients with major depression

  1997cited by this paper
• Number needed to treat is a simple measure of treatment efficacy for clinicians

  1996cited by this paper
• Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics

  1996cited by this paper
• Anticonvulsant drugs for management of pain: a systematic review

  1995cited by this paper
• The number needed to treat: a clinically useful measure of treatment effect

  1995cited by this paper
• Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists.

  1995cited by this paper
• A Practical Two-Step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy

  1994cited by this paper
• Incorporating variations in the quality of individual randomized trials into meta-analysis.

  1992cited by this paper
• Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.

  1992cited by this paper
• Textbook of pain

  1989cited by this paper
• An assessment of clinically useful measures of the consequences of treatment.

  1988cited by this paper

• Investigating the effect of aerobic exercise on the neuropathy symptoms caused by chemotherapy

  2024cites this paper
• Clinical insights into traumatic injury of the inferior alveolar and lingual nerves: a comprehensive approach from diagnosis to therapeutic interventions

  2024cites this paper
• Effectiveness of Duloxetine versus Other Therapeutic Modalities in Patients with Diabetic Neuropathic Pain: A Systematic Review and Meta-Analysis

  2024cites this paper
• Diabetische Neuropathie und diabetischer Fuß (Update 2023)

  2023cites this paper
• Neuropathic Pain in Neurologic Disorders: A Narrative Review

  2022cites this paper
• Comparison of the Efficacy and Safety of Duloxetine and Gabapentin in Diabetic Peripheral Neuropathic Pain: A Meta-Analysis

  2022cites this paper
• Pharmacotherapy of Painful Diabetic Neuropathy: A Clinical Update

  2022cites this paper
• Considerations for single- versus multiple-drug pharmacotherapy in the management of painful diabetic neuropathy

  2021cites this paper
• Comparison of efficacy and safety of gabapentin and duloxetine in painful diabetic peripheral neuropathy: A systematic review and meta‐analysis of randomised controlled trials

  2021cites this paper
• Diabetic Neuropathy

  2020cites this paper
• Recomendaciones para el tratamiento del dolor neuropático

  2020cites this paper
• Nonopioid Pharmacologic Treatments for Chronic Pain

  2020cites this paper
• Guideline “diagnosis and non interventional therapy of neuropathic pain” of the German Society of Neurology (deutsche Gesellschaft für Neurologie)

  2020cites this paper
• Extensive selective reporting of quality of life in clinical study reports and publications of placebo-controlled trials of antidepressants

  2020cites this paper
• Diabetes and the Nervous System

  2020cites this paper
• S2k-Leitlinie: Diagnose und nicht interventionelle Therapie neuropathischer Schmerzen

  2019cites this paper
• A Delphi consensus statement of the Neuropathic Pain Special Interest Group of the Italian Neurological Society on pharmacoresistant neuropathic pain

  2019cites this paper
• Comparison of venlafaxine and duloxetine: measuring clinical impact of time to therapeutic dose (TTD) among patients achieving therapeutic dosing for pain

  2018cites this paper
• Drug-induced movement disorder and confusion associated with duloxetine

  2018cites this paper
• Mirogabalin and emerging therapies for diabetic neuropathy

  2018cites this paper
• ACTUALIZACIÓN DEL TRATAMIENTO DE LA POLINEUROPATÍA DIABÉTICA PERIFÉRICA DOLOROSA 2015. COMITÉ DE NEUROPATÍA DIABÉTICA. SOCIEDAD ARGENTINA DE DIABETES

  2018cites this paper
• Postherpetic Neuralgia: Difficult to Treat, Easier to Prevent

  2017cites this paper
• Duloxetine Plasma Concentrations and Its Effectiveness in the Treatment of Nonorganic Chronic Pain in the Orofacial Region

  2017cites this paper
• A review of Neuropathic Pain: From Guidelines to Clinical Practice

  2017cites this paper
• Disruption of 5-HT2A-PDZ protein interaction differently affects the analgesic efficacy of SSRI, SNRI and TCA in the treatment of traumatic neuropathic pain in rats.

  2017cites this paper
• Evaluation of Predictors for Persistent Pain Post-total Knee Replacement

  2017cites this paper
• A 52-Year-Old Woman With Disabling Peripheral Neuropathy

  2017cites this paper
• Prevalence and Treatment of Neuropathic Pain in Kidney and Liver Transplant Recipients.

  2017cites this paper
• Diabetic Peripheral and Autonomic Neuropathy

  2016cites this paper
• Yoga and Physical Therapy: Integrating as a way of Life in Cancer Patients

  2016cites this paper
• Pharmacological Management of Neuropathic Pain: Current Trends and Possible Approaches

  2016cites this paper
• REVISTA DE LA SOCIEDAD ESPAÑOLA DEL DOLOR

  2016cites this paper
• [Recommendations for treatment and prevention of herpes zoster and associated pain in aged adults].

  2016cites this paper
• Understanding and treating painful diabetic neuropathy: time for a paradigm shift

  2015cites this paper
• Is duloxetine's effect on painful physical symptoms in depression an indirect result of improvement of depressive symptoms? Pooled analyses of three randomized controlled trials

  2015cites this paper
• Traitement médicamenteux des douleurs neuropathiques

  2015cites this paper
• ПАТОГЕНЕТИЧЕСКАЯ ТЕРАПИЯ НЕВРОПАТИЧЕСКОЙ БОЛИ ПРИ ДИАБЕТИЧЕСКОЙ ПОЛИНЕВРОПАТИИ

  2015cites this paper
• Comparative Evaluation of Pregabaline, Gabapentine, Sertraline and Duloxetine in Painful Diabetic Non Insulin-dependent Neuropathy☆

  2015cites this paper
• Pharmacological options for the management of refractory cancer pain—what is the evidence?

  2015cites this paper
• Neuropathie bei Diabetes im Erwachsenenalter

  2015cites this paper
• Neurologic Complications of Diabetes

  2014cites this paper
• Neuropathic cancer pain: What we are dealing with? How to manage it?

  2014cites this paper
• Diabetic peripheral neuropathy: current perspective and future directions.

  2014cites this paper
• Neuropathic cancer pain: what we are dealing with? How to manage it?

  2014cites this paper
• Neuropathic cancer pain: what we are dealing with? How to manage it?

  2014cites this paper
• Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia.

  2014cites this paper
• Combining Opioid and Adrenergic Mechanisms for Chronic Pain

  2014cites this paper
• Rapid Management of Trigeminal Neuralgia and Comorbid Major Depressive Disorder With Duloxetine

  2014cites this paper
• Global guideline for type 2 diabetes.

  2014cites this paper
• Therapy for diabetic neuropathy: an overview.

  2014cites this paper
• Chronic neuropathic pain in SCI: evaluation and treatment.

  2014cites this paper
• Diabetic neuropathy.

  2014cites this paper
• Management of Severe Neuropathic Cancer Pain

  2013cites this paper
• Pharmacologic management of diabetic peripheral neuropathic pain

  2013cites this paper
• Guidelines in the management of diabetic nerve pain: clinical utility of pregabalin

  2013cites this paper
• Chinese Medicinal Formula (MHGWT) for Relieving Diabetic Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Trial

  2013cites this paper
• A Review of Duloxetine 60 mg Once‐Daily Dosing for the Management of Diabetic Peripheral Neuropathic Pain, Fibromyalgia, and Chronic Musculoskeletal Pain Due to Chronic Osteoarthritis Pain and Low Back Pain

  2013cites this paper
• Advances in Pharmaceutical Options and Current Clinical Trials for the Treatment of Painful Diabetic Polyneuropathy

  2013cites this paper
• Diabetic Neuropathy and Oxidative Stress: Therapeutic Perspectives

  2013cites this paper
• Neuropathic itch: diagnosis and management

  2013cites this paper
• Патогенез, классификация, клиника и лечение диабетической полинейропатии

  2013cites this paper
• Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.

  2013cites this paper
• Mechanisms and Management of Diabetic Painful Distal Symmetrical Polyneuropathy

  2013cites this paper
• Review of Efficacy and Safety of Duloxetine 40 to 60 mg Once Daily in Patients with Diabetic Peripheral Neuropathic Pain

  2012cites this paper
• Economic evaluation of duloxetine as a first-line treatment for painful diabetic peripheral neuropathy in Mexico

  2012cites this paper
• Antidepressants for the Treatment of Chronic Pain

  2012cites this paper
• Acute Massive Pulmonary Thromboembolism Due to Acute Intoxication by Duloxetine: A Case Report

  2012cites this paper
• Pharmacological Treatment of Neuropathic Cancer Pain: A Comprehensive Review of the Current Literature

  2012cites this paper
• Management of Painful Diabetic Neuropathy: Guideline Guidance or Jungle?

  2012cites this paper
• Pharmacotherapy in patients with painful diabetic neuropathy: what do recent guidelines tell us?

  2012cites this paper
• Antinociceptive Effects of Monoamine Reuptake Inhibitors in Assays of Pain-Stimulated and Pain-Depressed Behaviors

  2012cites this paper
• Douleurs zostériennes et postzostériennes chez la personne âgée: analyse des évidences pour une prise en charge adaptée

  2012cites this paper
• Nationale VersorgungsLeitlinie Neuropathie bei Diabetes im Erwachsenenalter

  2012cites this paper
• Complex Regional Pain Syndrome of the Knee

  2012cites this paper
• Современные принципы ведения больных с диабетической полинейропатией

  2012cites this paper
• Management of Neuropathic Pain

  2011cites this paper
• Pharmacological management of persistent pain in older persons.

  2011cites this paper
• Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management

  2011cites this paper
• A Comparative Trial to Evaluate Amitriptyline and Duloxetine in Painful Diabetic Neuropathy: A randomized, double-blind, cross-over clinical trial

  2011cites this paper
• Treating pain in multiple sclerosis

  2011cites this paper
• Duloxetine use in painful conditions

  2011cites this paper
• Current concepts in the management of diabetic polyneuropathy.

  2011cites this paper
• Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury

  2011influential citation
• Antidepressivos de nova geração na neuropatia diabetica dolorosa

  2011cites this paper
• Review: Electrical spinal cord stimulation in painful diabetic polyneuropathy, a systematic review on treatment efficacy and safety

  2011influential citation
• Evidence for a differential opioidergic involvement in the analgesic effect of antidepressants: prediction for efficacy in animal models of neuropathic pain?

  2011influential citation
• Nontricyclic antidepressant analgesics and pain: Are serotonin norepinephrine reuptake inhibitors (SNRIs) any better?

  2011cites this paper
• New Generation Antidepressants in Painful Diabetic Neuropathy

  2011cites this paper
• Artículos originales New Generation Antidepressants in Painful Diabetic Neuropathy

  2011cites this paper
• A Comparative Evaluation of Amitriptyline and Duloxetine in Painful Diabetic Neuropathy

  2011cites this paper
• Recent advances in the management of diabetic distal symmetrical polyneuropathy

  2011cites this paper
• Painful Diabetic Neuropathy in Clinical Practice

  2011cites this paper
• Therapeutic Strategies for Diabetic Neuropathy

  2010cites this paper
• Les douleurs neuropathiques chroniques: diagnostic, évaluation, traitement en médecine ambulatoire. Recommandation pour la pratique clinique de la Société Française d’étude et de Traitement de la Douleur

  2010cites this paper
• NICE guidelines for the management of painful diabetic neuropathy

  2010cites this paper
• Les douleurs neuropathiques chroniques : diagnostic, évaluation et traitement en médecine ambulatoire. Recommandations pour la pratique clinique de la Société française d’étude et de traitement de la douleur

  2010cites this paper
• Antidepressant treatment of neuropathic pain: looking for the mechanism

  2010cites this paper
• Emerging drugs for diabetic neuropathy

  2010cites this paper
• Duloxetine: Its Role in the Management of Chronic Pain

  2010cites this paper
• Chapter 26. Treatment of Neuropathic Pain

  2010cites this paper